Advise patients at the beginning of treatment that their menstrual cycle may be disrupted and that irregular and unpredictable bleeding or spotting results, and that this usually decreases to the point of amenorrhea as treatment with Depo-Provera CI continues, without other therapy being required. Cou...
Provera Dosage and Administration Secondary Amenorrhea PROVERA tablets may be given in dosages of 5 or 10 mg daily for 5 to 10 days. A dose for inducing an optimum secretory transformation of an endometrium that has been adequately primed with either endogenous or exogenous estrogen is 10 mg of...
What is the dosage for medroxyprogesterone? The usual dose of medroxyprogesterone tablets is 5 or 10 mg daily. Secondaryamenorrheais treated for 5 to 10 days. Uterine bleeding is treated for 5 to 10 days beginning on day 16 or 21 of the menstrual cycle. Endometrial hyperplasia is treated for...
While the levels of Depo-Provera after 90 days may not be high enough to be considered effective for pregnancy prevention, they may still be too high to get pregnant Your chance of getting pregnant while using Depo Proverais 0. The woman can be pregnant even. Amenorrhea - Absence of Menstru...
The use of depo-subQ provera 104 is not recommended as a long-term (i.e., longer than 2 years) birth control method or medical therapy for endometriosis-associated pain unless other options are considered inadequate [see Dosage and Administration (2.1) and Warnings and Precautions (5.1)].2...
Depo-Provera - Get up-to-date information on Depo-Provera side effects, uses, dosage, overdose, pregnancy, alcohol and more. Learn more about Depo-Provera
Dosage and Administration Depo-Provera and DepoSubQ-Provera are birth control shots administered by health care providers. In some cases, DepoSubQ-Provera can be self-administered by patients. The following are guidelines from the drugs’ prescription information label. ...
missed periods (amenorrhea), bleeding and spotting between periods, heavier bleeding during the first few weeks after device insertion, abdominal/pelvicpain, ovariancysts, back pain, headache/migraine, nervousness, dizziness, nausea, vomiting,
Dosage Forms & Strengths tablet 2.5mg 5mg 10mg injectable IM suspension 150mg/mL 400mg/mL prefilled syringe suspension 104mg/0.65mL Metastatic Endometrial Carcinoma Depo-Provera only Indicated for adjunctive therapy and palliative treatment of inoperable, recurrent, and metastatic endometrial carcinoma...
The success rate of Depo-Provera as a contraceptive agent on a 90 day regimen was 99.3%. It is the conclusion of the study that this dosage of Depo-Provera appears to be accepted and tolerated by parous women in the Calcutta region. 展开 ...